Supplement GMP Inspections Reveal Adverse Event Reports, Prompting Warning Letters
This article was originally published in The Tan Sheet
Executive Summary
About 13% of the 156 warning letters FDA sent to dietary supplement firms from 2011 through June 2014 cited firms for failing to report serious adverse events or for not providing on product labels a domestic address or phone number at which to receive AERs. The citation total has climbed steadily from 2011.
You may also be interested in...
Final AER Guidance Requires Full Address, Recommends Prefatory Language
In its final adverse event reports labeling guidance documents released Sept. 1, FDA does not budge on defining "domestic address" as a full mailing address, or on recommending labels include statements directing consumers how to submit AERs
CHPA board
Perrigo Consumer Healthcare Executive VP & General Manager John Hendrickson has been elected chair of the Consumer Healthcare Products Association by the group's Board of Directors, CHPA announces March 17 during its annual meeting in Aventura, Fla. The group announced Hendrickson as chair-elect in November (1"The Tan Sheet" Nov. 28, 2005, In Brief). Hendrickson succeeds Timothy Hayes of Bayer Healthcare, who will now serve as immediate past chair. In addition, the association, which was founded in 1881, is celebrating its 125th anniversary by unveiling a new, more "modern" logo, President Linda Suydam said...
J&J Consumer Sales Slip Even As Recalled Brands, Seasonal Items Reach Stores
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.